Related Experiment Video
Updated: Sep 27, 2025

09:10
Murine Salivary Functional Assessment via Pilocarpine Stimulation Following Fractionated Radiation
Published on: May 4, 2018
11.5K
Olfactory Sensations During Proton and Photon Radiotherapy: A Multicenter Prospective Observational Study
Masashi Mizumoto1, Yoshiko Oshiro2, Taisuke Sumiya1
1Radiation Oncology, University of Tsukuba Hospital, Tsukuba, JPN.
Cureus
|April 12, 2022
Summary
A sense of smell during radiation therapy (RT) is common, particularly with photon RT. Higher nasal cavity radiation doses and younger age increase the likelihood of experiencing this sensation.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Patients undergoing radiation therapy (RT) sometimes report olfactory sensations.
- The characteristics and contributing factors of these smell events are not fully understood.
Purpose of the Study:
- To investigate the occurrence and nature of smell sensations during photon RT and proton beam therapy (PBT).
- To identify factors associated with smell perception during RT.
Main Methods:
- Prospective study of adult patients undergoing photon RT or PBT between January 2019 and August 2020.
- Weekly checklists recorded smell presence, odor type, intensity, and timing.
- Exclusion criteria included communication difficulties and pre-existing olfactory abnormalities.
Main Results:
- Smell was reported by 8.2% of 620 patients (649 courses).
- Nasal cavity radiation dose, younger age, and photon RT were significantly associated with smell perception.
- Smell incidence increased with higher nasal cavity dose (4.5% with no irradiation to 27.9% with 60%-100% isodose).
- Photon RT (10.4%) resulted in more smell reports than PBT (3.9%).
- The most common smell reported was 'burnt' (63%).
Conclusions:
- Olfactory sensations are a notable phenomenon during RT.
- Nasal cavity radiation dose, patient age, and RT modality (photon vs. proton) are key factors influencing smell perception.
- These findings aid in understanding patient-reported symptoms during RT.
Related Concept Videos
Olfactory Receptors: Location and Structure
9.7K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.7K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
347
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
347
Olfaction
45.3K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
45.3K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
379
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
379

